Morepen Laboratories
Ticker >

Morepen Laboratories share price

Morepen Laboratories Ltd.

NSE: MOREPENLAB BSE: 500288 SECTOR: Pharmaceuticals & Drugs  169k   1k   242

48.63
+2.06 (4.42%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 49.8

Today's Low

₹ 45.51

52 Week High

₹ 56.35

52 Week Low

₹ 25.34

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2485.81 Cr.

Enterprise Value

₹ 2455.07 Cr.

No. of Shares

51.12 Cr.

P/E

30.59

P/B

2.92

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  16.65

CASH

₹ 55.9 Cr.

DEBT

₹ 25.16 Cr.

Promoter Holding

38.22 %

EPS (TTM)

₹  1.59

Sales Growth

-7.62%

ROE

6.84 %

ROCE

9.15%

Profit Growth

-54.24 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Morepen Laboratories Ltd.

Forever Young Burnol Lemolate Fibre-X QuickChek Exygra Itch Beat 2 Kool Hair Oil

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-7.62%
3 Year19.13%
5 Year19.01%

Profit Growth

1 Year-54.24%
3 Year12.67%
5 Year12.11%

ROE%

1 Year6.84%
3 Year18.07%
5 Year15.22%

ROCE %

1 Year9.15%
3 Year19.14%
5 Year15.19%

Debt/Equity

0.0323

Price to Cash Flow

-24.34

Interest Cover Ratio

32.8265852180937

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 38.22 0
Sep 2023 38.22 0
Jun 2023 38.22 0
Mar 2023 38.22 0
Dec 2022 38.22 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 19.1262280376496% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 32.8265852180937.
  • The company has an efficient Cash Conversion Cycle of 36.3900259102245 days.
  • Company has a healthy liquidity position with current ratio of 2.51171316937245.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.70055211547648.

 Limitations

  • Company has negative cash flow from operations of -102.1154.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 344.62 336.52 369.1 381.26 394.63
Total Expenditure 323.17 321.4 344.3 351.5 343.52
Operating Profit 21.45 15.13 24.8 29.76 51.12
Other Income 1.19 2.99 2.08 2.84 3.66
Interest 0.55 0.56 0.28 0.46 2.04
Depreciation 4.56 4.61 4.89 4.81 5.51
Exceptional Items 0 0 0 0 0
Profit Before Tax 17.53 12.94 21.71 27.33 47.22
Tax 4.96 2.67 5.86 7.41 12.02
Profit After Tax 12.57 10.28 15.85 19.92 35.2
Adjusted EPS (Rs) 0.25 0.2 0.31 0.39 0.69

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 717.24 791.99 1112.42 1449.27 1338.88
Total Expenditure 652.22 727.52 1000.05 1320.13 1261.61
Operating Profit 65.02 64.47 112.37 129.14 77.27
Other Income 3.67 9.42 11.77 20.03 5.76
Interest 2.07 1.97 1.79 2.43 1.98
Depreciation 38.01 34.43 28.11 21.19 18.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 28.61 37.48 94.25 125.54 63.04
Tax 0 5.15 0 24.48 16.8
Net Profit 28.61 32.33 94.25 101.06 46.24
Adjusted EPS (Rs.) 0.64 0.72 2.1 2.12 0.9

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 89.96 89.96 89.96 95.56 102.23
Total Reserves 187.5 217.29 355.01 502.61 677.89
Borrowings 1.79 0.92 0.83 1.32 0.93
Other N/C liabilities 19.32 24.43 26.06 31.09 33.52
Current liabilities 320.82 329.38 375.63 402.69 290.98
Total Liabilities 619.39 661.99 847.5 1033.26 1105.54
Assets
Net Block 152.59 134.84 144.02 156.11 170.82
Capital WIP 0 0 1.96 14.15 17.01
Intangible WIP 0 0 0 0 0
Investments 117.69 118.78 118.78 117.79 117.84
Loans & Advances 65.49 59.83 89.67 68.17 68.74
Other N/C Assets 0.28 0.28 0.27 0.28 0.28
Current Assets 283.33 348.26 492.79 676.76 730.85
Total Assets 619.39 661.99 847.5 1033.26 1105.54
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 28.61 37.48 94.25 125.54 63.04
Adjustment 38.36 34.23 29.63 13.02 18.01
Changes in Assets & Liabilities -52.4 -55.33 -74.56 -183.04 -166.9
Tax Paid 0 -5.52 0 -24.39 -16.27
Operating Cash Flow 14.58 10.86 49.31 -68.87 -102.12
Investing Cash Flow -10.34 -12.08 -69.09 -22.64 -36.2
Financing Cash Flow -0.35 4.65 47.46 66.41 144.2
Net Cash Flow 3.89 3.43 27.68 -25.09 5.88

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 38.22 38.22 38.22 38.22 38.22
aakriti suri - 0.01 0.01 0.01 0.01
aanandi suri 0.15 0.15 0.15 0.15 0.15
aanchal suri 0.13 0.13 0.13 0.13 0.13
anju suri 1.01 1.01 1.01 1.01 1.01
anubhav suri 0.15 0.15 0.15 0.15 0.15
anubhav suri (arun suri s... 0.29 0.29 0.29 0.29 0.29
brook investments and fin... 2.97 2.97 2.97 2.97 2.97
concept credits and consu... 3.00 3.00 3.00 3.00 3.00
epitome holdings pvt.ltd.... 2.84 2.84 2.84 2.84 2.84
gulfy malhotra - - - 0.22 0.22
kanak suri 0.20 0.20 0.20 0.20 0.20
liquid holdings pvt. ltd.... 0.98 0.98 0.98 0.98 0.98
mamta suri 0.59 0.59 0.59 0.59 0.59
master arjun suri 0.14 0.14 0.14 0.14 0.14
mid med financial service... 2.93 2.93 2.93 2.93 2.93
p.l. suri 0.08 0.08 0.08 0.08 0.08
rajas suri 0.03 0.03 0.03 0.03 0.03
rajas suri (kb suri sons ... 0.19 0.19 0.19 0.19 0.19
react investments and fin... 2.92 2.92 2.92 2.92 2.92
sanjay suri 0.67 0.67 0.67 0.67 0.67
sanjay suri (sanjay suri ... 0.41 0.41 0.41 0.41 0.41
sara suri 0.14 0.14 0.14 0.14 0.14
scope credits and financi... 3.05 3.05 3.05 3.05 3.05
seed securities and servi... 2.80 2.80 2.80 2.80 2.80
shalu suri 0.40 0.40 0.40 0.40 0.40
solace investments and fi... 2.95 2.95 2.95 2.95 2.95
solitary investments and ... 2.96 2.96 2.96 2.96 2.96
sonia pankaj bajaj - - - 0.72 0.72
square investments and fi... 2.76 2.76 2.76 2.76 2.76
sunita suri 0.62 0.62 0.62 0.62 0.62
sushil suri 1.08 1.08 1.08 1.08 1.08
sushil suri (sushil suri ... 0.24 0.24 0.24 0.24 0.24
varun suri 0.60 0.60 0.60 0.60 0.60
gulfy suri 0.22 0.22 0.22 - -
sonia suri 0.72 0.72 0.72 - -
baby aakriti suri 0.01 - - - -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 61.78 61.78 61.78 61.78 61.78
damodar prasad agarwal 1.42 1.26 1.27 1.10 1.03
morepen laboratories limi... - - - 1.04 1.04
pinfold overseas limited 7.54 7.54 7.54 7.54 7.54
morepen laboratories ltd - - 1.04 - -
morepen laboratories limi... 1.04 1.04 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Morepen Laboratories informs about outcome of EGM 18 Mar 2024, 4:13PM Morepen Laboratories informs about outcome of board meeting 31 Jan 2024, 3:59PM Morepen Laboratories - Quaterly Results31 Jan 2024, 2:22PM Morepen Laboratories - Quaterly Results31 Jan 2024, 2:22PM Morepen Laboratories - Quaterly Results31 Jan 2024, 2:22PM Morepen Laboratories informs about loss of share certificate16 Dec 2023, 3:39PM Morepen Laboratories informs about issuance of letter(s) of confirmation23 Nov 2023, 12:43PM Morepen Laboratories informs about loss of share certificate16 Nov 2023, 2:53PM Morepen Laboratories informs about newspaper advertisements4 Nov 2023, 3:02PM Morepen Laboratories - Quaterly Results2 Nov 2023, 2:23PM Morepen Laboratories - Quaterly Results2 Nov 2023, 2:23PM Morepen Laboratories - Quaterly Results2 Nov 2023, 2:23PM Morepen Laboratories informs about details of loss of certificate 30 Oct 2023, 4:47PM Morepen Laboratories informs about outcome of board meeting5 Aug 2023, 4:14PM Morepen Laboratories - Quaterly Results5 Aug 2023, 2:26PM Morepen Laboratories - Quaterly Results5 Aug 2023, 2:26PM Morepen Laboratories - Quaterly Results5 Aug 2023, 2:26PM Morepen Laboratories informs about issuance of letter of confirmation11 Jul 2023, 9:41AM Morepen Laboratories informs about loss of share certificates3 Jul 2023, 4:57PM Morepen Laboratories - Quaterly Results16 May 2023, 4:29PM Morepen Laboratories - Quaterly Results16 May 2023, 4:29PM Morepen Laboratories - Quaterly Results16 May 2023, 4:29PM USFDA conducts inspection of Morepen Laboratories’ API manufacturing facility at Baddi27 Mar 2023, 2:08PM Morepen Laboratories incorporates wholly owned subsidiary18 Mar 2023, 11:05AM Morepen Laboratories informs about details of loss of certificate17 Feb 2023, 5:03PM Morepen Laboratories - Quaterly Results13 Feb 2023, 1:58PM Morepen Laboratories - Quaterly Results13 Feb 2023, 1:58PM Morepen Laboratories - Quaterly Results13 Feb 2023, 1:58PM Morepen Laboratories informs about loss of share certificate7 Feb 2023, 5:06PM Morepen Laboratories informs about loss of share certificate17 Jan 2023, 5:17PM Morepen Laboratories - Quaterly Results10 Nov 2022, 1:51PM Morepen Laboratories - Quaterly Results10 Nov 2022, 1:51PM Morepen Laboratories - Quaterly Results10 Nov 2022, 1:51PM Morepen Laboratories - Quaterly Results29 Jul 2022, 1:47PM Morepen Laboratories - Quaterly Results29 Jul 2022, 1:47PM Morepen Laboratories - Quaterly Results29 Jul 2022, 1:47PM Morepen Laboratories informs about allotment of equity shares9 May 2022, 4:24PM Morepen Laboratories informs about press release5 May 2022, 3:27PM Morepen Laboratories - Quaterly Results5 May 2022, 1:32PM Morepen Laboratories - Quaterly Results5 May 2022, 1:32PM Morepen Laboratories - Quaterly Results5 May 2022, 1:32PM Morepen Laboratories informs about clarification11 Apr 2022, 12:29PM Morepen Laboratories - Quaterly Results8 Feb 2022, 11:59AM Morepen Laboratories - Quaterly Results8 Feb 2022, 11:59AM Morepen Laboratories - Quaterly Results8 Feb 2022, 11:59AM Morepen Laboratories informs about loss of share certificate23 Dec 2021, 12:46PM Morepen Laboratories gets USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride3 Dec 2021, 12:43PM Morepen Laboratories informs about board meeting3 Nov 2021, 3:36PM Morepen Laboratories informs about loss of share certificates18 Oct 2021, 12:19PM Morepen Laboratories informs about press release29 Sep 2021, 10:42AM

Morepen Laboratories Stock Price Analysis and Quick Research Report. Is Morepen Laboratories an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Morepen Laboratories and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Morepen Laboratories cash from the operating activity was Rs -102.1154 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Morepen Laboratories has a Debt to Equity ratio of 0.0323 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Morepen Laboratories , the EPS growth was -57.2286308623298 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Morepen Laboratories has OPM of 5.77121247236408 % which is a bad sign for profitability.
     
  • ROE: Morepen Laboratories have a poor ROE of 6.84050731665754 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Morepen Laboratories is Rs 47.45. One can use valuation calculators of ticker to know if Morepen Laboratories share price is undervalued or overvalued.
Last Updated on:
Brief about Morepen Laboratories

Morepen Laboratories Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Morepen Laboratories Ltd. is a leading pharmaceutical company in India that specializes in the manufacturing and supply of bulk drugs, formulations, diagnostics, and APIs. With a rich history of more than three decades, Morepen has established itself as a trusted name in the healthcare industry. The company is known for its commitment to quality, innovation, and customer satisfaction.

Morepen Laboratories Ltd. - Share Price

Stay updated with the latest share price of Morepen Laboratories Ltd. Our website provides real-time information on the stock's performance in the market. By tracking the share price, investors can make informed decisions regarding buying, selling, or holding their positions in Morepen Laboratories Ltd.

Morepen Laboratories Ltd. - Balance Sheet

Access the balance sheet of Morepen Laboratories Ltd. to get a comprehensive understanding of the company's financial position. Our pre-built screening tools enable investors to analyze the balance sheet and identify key financial indicators without the need for complex calculations. We provide downloadable annual reports that serve as a valuable resource for conducting a thorough analysis.

Morepen Laboratories Ltd. - Annual Report

The annual report of Morepen Laboratories Ltd. contains a wealth of information that can assist investors in evaluating the company's performance over the past year. Our website offers downloadable annual reports, enabling investors to gain insights into the company's financials, business strategies, and future prospects.

Morepen Laboratories Ltd. - Dividend

Discover the dividend history of Morepen Laboratories Ltd. by exploring our website. Investors interested in dividend income can track the company's dividend payouts over the years. Our platform provides a user-friendly interface where investors can access the latest dividend announcements and historical dividend data.

Morepen Laboratories Ltd. - Quarterly Result

Stay updated with the quarterly results of Morepen Laboratories Ltd. Our website provides access to the company's financial performance for each quarter. Investors can analyze the quarterly reports, along with our premium features such as fair value calculation using tools like DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Morepen Laboratories Ltd. - Stock Price

Track the stock price of Morepen Laboratories Ltd. and monitor its movement in the market on a daily basis. Our website provides a comprehensive chart that displays the historical price data, allowing investors to identify trends and patterns. By understanding the stock price dynamics, investors can make informed decisions about their investment in Morepen Laboratories Ltd.

Morepen Laboratories Ltd. - Price Chart

Our website offers an interactive price chart that allows investors to visualize the historical price movement of Morepen Laboratories Ltd. This tool enables users to analyze the stock's performance over different time frames and identify trends, support, and resistance levels. The price chart serves as a valuable resource for technical analysis.

Morepen Laboratories Ltd. - News

Stay updated with the latest news and developments related to Morepen Laboratories Ltd. Our website provides a dedicated news section where investors can access relevant news articles, press releases, and market updates. By staying informed, investors can make well-informed decisions based on the latest information.

Morepen Laboratories Ltd. - Concall Transcripts

Access the concall transcripts of Morepen Laboratories Ltd. to gain insights into the company's quarterly earnings calls and management discussions. Our platform offers downloadable concall transcripts, enabling investors to study the key highlights, decisions, and future plans discussed during these calls.

Morepen Laboratories Ltd. - Investor Presentations

Morepen Laboratories Ltd. regularly publishes investor presentations that provide an overview of the company's operations, financial performance, and growth prospects. Our platform offers downloadable investor presentations, allowing investors to delve into the details and understand the dynamics of Morepen Laboratories Ltd.

Morepen Laboratories Ltd. - Promoters

Learn about the promoters of Morepen Laboratories Ltd. and their contribution to the company's growth and success. Our website provides detailed information about the promoters, their background, and the roles they play in the company's management and decision-making processes.

Morepen Laboratories Ltd. - Shareholders

Discover the major shareholders of Morepen Laboratories Ltd. and their influence on the company's governance and strategic decisions. Our platform offers insights into the shareholding pattern of the company, providing investors with a holistic view of the ownership structure.

With our website’s comprehensive resources and pre-built screening tools, investors can conduct a thorough stock analysis of Morepen Laboratories Ltd. Make use of our downloadable annual reports, concall transcripts, investor presentations, and other valuable features to gain a deeper understanding of the company's financial health, market performance, and growth potential.

Read More
X